Leadership Overview
Clin-nov Medical has 6 executives leading key functions including strategy, technology, finance, and operations.
Driven by scientific advancement, Clin-nov Medical is dedicated to providing comprehensive drug research and development solutions, leveraging cutting-edge technologies to accelerate new treatments for global patients.
Driven by scientific advancement, Clin-nov Medical is dedicated to providing comprehensive drug research and development solutions, leveraging cutting-edge technologies to accelerate new treatments for global patients.
Leadership Roles at Clin-nov Medical
Rui Yang - Chief Executive Officer
Rui Yang, the Chief Executive Officer at Clin-nov Medical, directs the overarching corporate strategy and vision. Overseeing all business units, Rui Yang ensures alignment with the company's core mission of advancing drug research and development. This leadership role involves guiding the organization's scientific direction and market positioning within the pharmaceutical industry. By fostering innovation, Rui Yang drives the company's commitment to utilizing advanced technologies to bring new treatments to patients worldwide. The Chief Executive Officer's focus remains on expanding the company's capabilities as a Contract Research Organization (CRO) and solidifying its reputation for scientific excellence. Rui Yang's strategic decisions directly impact the company's growth and its ability to serve the global healthcare landscape.
Da Zhang - Chief Financial Officer
Da Zhang, the Chief Financial Officer at Clin-nov Medical, manages all financial operations and strategic fiscal planning. Overseeing the company's financial health, Da Zhang ensures robust resource allocation to support research and development initiatives. This position is integral to maintaining the financial stability required for a Contract Research Organization (CRO) operating in the pharmaceutical sector. By guiding financial strategies, the Chief Financial Officer directly supports Clin-nov Medical's mission to advance new treatments for patients globally. Da Zhang's oversight extends to investment decisions, budget management, and ensuring compliance with financial regulations. The Chief Financial Officer's acumen is essential for sustainable growth and the effective deployment of capital in pursuit of scientific breakthroughs.
Qi Yin - Chief Operating Officer & Head Chief Strategy Officer (US)
Qi Yin, the Chief Operating Officer & Head Chief Strategy Officer (US) at Clin-nov Medical, directs operational execution and strategic planning within the United States. Overseeing day-to-day operations and long-term strategic development, Qi Yin ensures seamless service delivery for pharmaceutical clients. This dual role is crucial for translating scientific objectives into tangible operational outcomes and market strategies. By managing operational efficiency, the Chief Operating Officer & Head Chief Strategy Officer (US) enhances the company's capacity to provide comprehensive drug research solutions. Qi Yin's leadership focuses on optimizing processes and driving growth in the US market, reinforcing Clin-nov Medical's commitment to advancing patient treatments. The strategic direction set by Qi Yin is fundamental to the company's success in the competitive R&D landscape.
Yin Qi - Chief Operating Officer and CSO
Yin Qi, the Chief Operating Officer and CSO at Clin-nov Medical, spearheads operational excellence and corporate strategy. Overseeing global operational frameworks, Yin Qi ensures the efficient execution of drug research and development projects. This leadership position is vital for integrating strategic goals with practical operational management, driving the company's mission forward. By optimizing operational workflows, the Chief Operating Officer and CSO enhances Clin-nov Medical's ability to deliver advanced solutions to the pharmaceutical industry. Yin Qi's focus is on streamlining processes and fostering a culture of continuous improvement across all departments. The strategic insights provided by Yin Qi are instrumental in navigating market dynamics and achieving long-term organizational objectives.
Ruiling Peng - Chief Technology Officer
Ruiling Peng, the Chief Technology Officer at Clin-nov Medical, architects the technological infrastructure supporting drug research and development. Overseeing all technology initiatives, Ruiling Peng ensures the company leverages state-of-the-art solutions to accelerate treatment advancements. This critical role involves evaluating and implementing new technologies that enhance the efficiency and effectiveness of the Contract Research Organization's (CRO) services. By driving technological innovation, the Chief Technology Officer directly contributes to Clin-nov Medical's ability to offer comprehensive drug research solutions to the pharmaceutical industry. Ruiling Peng's expertise is vital in maintaining the company's scientific forefront and its commitment to patient-focused outcomes. The Chief Technology Officer's strategic vision ensures the company remains at the cutting edge of R&D technology.
Xinhui Hu - Chief Technology Officer, Cbo
Xinhui Hu, the Chief Technology Officer, Cbo at Clin-nov Medical, leads technological innovation and business development initiatives. Overseeing the integration of advanced technologies with market opportunities, Xinhui Hu drives the company's growth strategy. This role is essential for identifying and capitalizing on new avenues for drug research and development services. By fostering strategic partnerships and technological advancements, the Chief Technology Officer, Cbo directly supports Clin-nov Medical's commitment to accelerating patient treatment solutions. Xinhui Hu's expertise bridges the gap between cutting-edge R&D capabilities and market demand, ensuring the company remains competitive. The business development focus led by Xinhui Hu is critical for expanding the company's reach and impact within the pharmaceutical sector.
Explore Leadership Teams in Business Services
Battelle Memorial Institute, founded in 1929 and headquartered in Columbus, Ohio, is a charitable organization that applies science and technology to solve critical challenges. Operating through major technology centers and national laboratories worldwide, Battelle specializes in research and development, product manufacturing, and delivering essential services for government and commercial clients. The organization focuses on advancing solutions in national security, health and life sciences, and energy and environmental industries. With facilities across multiple continents including North America, Europe, Asia, and the Middle East, Battelle maintains a global presence in scientific innovation and technological development.
Company Leadership
PC
HG
Founded in 2014 and headquartered in London, Roivant Sciences is a tech-enabled healthcare company focused on completing the development of promising late-stage drug candidates and delivering innovative healthcare technologies to patients.
Company Leadership
DC
Ascential Technologies delivers design, development and manufacturing solutions that tackle the toughest problems, unlocking performance for mission-critical companies. With global scale, deep expertise and practical know-how born from seven decades on the cutting edge of automation, Ascential partners with customers every step of the way to accelerate and realize their innovations. We deliver a range of offerings, from the most complex diagnostic tools used in life sciences, to the development and testing of adaptive safety systems in electric vehicles, to the inspection of advanced microprocessors for functional integrity and much more. Through our diverse portfolio of solutions, Ascential helps customers accelerate their innovation, mitigate risk, drive competitive differentiation, and reduce time to market at scale.
Company Leadership
GD
DB
SO
Lloyd's Register Group Limited (LR) is a technical and professional services organisation and a maritime classification society, wholly owned by the Lloyds Register Foundation, a UK charity dedicated to research and education in science and engineering. The organisation dates to 1760. Its stated aims are to enhance the safety of life, property, and the environment, by helping its clients (including by validation, certification, and accreditation) to improve the safety and performance of complex projects, supply chains and critical infrastructure. In July 2012, the organisation converted from an industrial and provident society to a company limited by shares, named Lloyds Register Group Limited, with the new Lloyds Register Foundation as the sole shareholder. At the same time the organisation gave to the Foundation a substantial bond and equity portfolio to assist it with its charitable purposes. It will benefit from continued funding from the groups operating arm, Lloyds Register Group Limited. In 2020, Lloyd's Register sold its Energy business Lloyd's Register is unaffiliated with Lloyd's of London, but emerged from the same professional and social circles that historically met at Lloyd's Coffee House, from which both organisations took their name.
Company Leadership ST
JH
DC
Frequently Asked Questions Regarding Clin-nov Medical Top Executives and Leadership Team
